The efficacy and toxicity of 4-day chemotherapy with methotrexate, etoposide and actinomycin D in patients with choriocarcinoma and high-risk gestational trophoblastic neoplasia.
Shizuka SatoEiko YamamotoKaoru NiimiKazuhiko InoKimihiro NishinoShiro SuzukiTomomi KotaniHiroaki KajiyamaFumitaka KikkawaPublished in: International journal of clinical oncology (2019)
The results suggest that the efficacy and the adverse effects of 4-day MEA for choriocarcinoma and high-risk GTN may be the same level as EMA/CO. However, further study will be needed for determining the criteria of changing the treatment regimen from 4-day MEA to the EA regimen.